We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Carbon Monoxide Therapy for Severe Pulmonary Arterial Hypertension (CO in PAH)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01523548
Recruitment Status : Withdrawn (Lack of funding and subject acuity)
First Posted : February 1, 2012
Last Update Posted : June 9, 2017
Sponsor:
Collaborators:
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
Roberto Machado, M.D., University of Illinois at Chicago

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : December 2018
  Estimated Study Completion Date : December 2018